Changes in hepatic parenchymal blood flow with colorectal metastases: Increase in arterial and decrease in portal blood flow

Hepato-Gastroenterology

Volumn 50, Issue 53, 2003, Pages 1457-1462

  Kunishima, Satoshi ^a,d   Taniguchi, Hiroki ^b   Yamaguchi, Akihiro ^c   Koh, Toshimori ^c   Yamagishi, Hisakazu ^c  

^a Kyoto Kizugawa Hospital   (Japan)

^b KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^c KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^d Kyoto Kizugawa Hospital   (Japan)

Author keywords

Blood flow in liver parenchyma; Colorectal hepatic metastasis; H215O dynamic method; Non tumorous blood flow; Positron emission tomography

Indexed keywords

ADULT; AGED; ARTERY BLOOD FLOW; ARTICLE; BLOOD FLOWMETRY; CLINICAL ARTICLE; CLINICAL TRIAL; COLORECTAL TUMOR; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HUMAN; LIVER BLOOD FLOW; LIVER METASTASIS; LIVER PARENCHYMA; MALE; METASTASIS; PORTAL VEIN BLOOD FLOW; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL;

ADULT; AGED; COLORECTAL NEOPLASMS; FEMALE; HUMANS; LIVER; LIVER NEOPLASMS; MALE; MIDDLE AGED; PORTAL SYSTEM; REGIONAL BLOOD FLOW; SPLEEN;

EID: 0141763499     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Suzuki M, Hori K, Abe I, Saito S, Sato H: A new approach to cancer chemotherapy: Selective enhancement of tumor blood flow with angiotensin-II. J Natl Cancer Inst 1981; 67:663-669.
2. Taniguchi H, Koyama H, Masuyama M, Takada A, Mugitani T, Tanaka H, et al: Angiotensin-II-induced hypertension chemotherapy: evaluation of hepatic blood flow with oxygen-15 PET. J Nucl Med 1996; 37:1522-1523.
3. Yamaguchi A, Taniguchi H, Kunishima S, Koh T, Yamagishi H: Correlation between angiographically assessed vascularity and blood flow in hepatic metastases from colorectal carcinoma. Cancer 2000; 89:1236-1244.
4. Leen E, Goldberg JA, Robertson J, Sutherland GR, McArdle CS: The use of duplex sonography in the detection of colorectal hepatic metastases. Br J Cancer 1991; 63:323-325.
5. Leen E, Goldberg JA, Anderson JR, Robertson J, Moule B, Cooke TG, et al: Hepatic perfusion changes in patients with liver metastases: comparison with those patients with cirrhosis. Gut 1993; 34:554-557.
6. Dugdale PE, Miles KA: Hepatic metastases: the value of quantitative assessment of contrast enhancement on computed tomography. Eur J Radiol 1999; 30:206-213.
7. Nelder JA, Mead R: A simplex method for function minimization. Computer J 1965; 7:308-313.
8. 15O -. Ann Nucl Med 1993; 7:141-145.
9. Taniguchi H, Oguro A, Koyama H, Masuyama M, Takahashi T: Analysis of models for quantification of arterial and portal blood flow in the human liver using PET. J Comput Assist Tomogr 1996; 20:135-144.
10. Taniguchi H, Yamaguchi A, Kunishima S, Koh T, Masuyama M, Koyama H, et al: Using the spleen for time-delay correction of the input function in measuring hepatic blood flow with 15-oxigen water by dynamic PET. Ann Nucl Med 1999; 13:215-221.
11. 2 steady state method. In: Takahashi T (Ed.). Recent advances in management of digestive cancer Tokyo: Springer-Verlag, 1993; pp. 631-633.
12. 15O and a dynamic state method 1 -. Ann Nucl Med 1993; 7:245-250.
13. Taniguchi H, Oguro A, Koyama H, Miyata K, Takeuchi K, Takahashi T: Determination of the spleen-blood partition coefficient for water with oxygen-15-water and oxygen-15-carbon dioxide dynamic PET steady state methods. J Nucl Med 1995; 36:599-602.
14. 2 steady state PET. Nuclear Med Commun 1999; 20:1147-1151.
15. Ackerman NB: Experimental studies on the circulatory dynamics of intrahepatic tumor blood supply. Cancer 1972; 29:435-439.
16. Honda H, Matsuura Y, Onitsuka H, Murakami J, Kaneko K, Murayama S, et al: Diiferential diagnosis of hepatic tumors (hepatoma, hemangioma, and metastasis) with CT: value of two-phase incremental imaging. AJR Am J Roentgenol 1992; 159:735-740.
17. Chang AE, Scnider PD, Sugarbaker PH: A prospective randomized trial of regional versus systemic continuous 5-fluorodeoxyuridine chemotherapy in the treatment of colorectal liver metastases. Ann Surg 1987; 206:685-693.
18. Hohn D, Stagg R, Friedman M: A randomized trial of continuous intravenous versus hepatic intra-arterial flox-uridine in patients with colorectal cancer metastatic to the liver: The Northern California Oncology Group Trial. J Clin Oncol 1989; 7:1646-1654.
19. Rougier P, Laplanche A, Huguier M, Hay JM, Ollivier JM, Escat J, et al: Hepatic arterial infusion of floxuridine in patients with liver metastases from colorectal cancer. A randomized trial. J Clin Oncol 1992; 10:1112-1118.
20. Allen-Mersh TG, Earlam S, Fordy C, Abrams K, Houghton J: Quality of life and survival with continuous hepatic artery floxuridine infusion for colorectal liver metastases. Lancet 1994; 344:1255-1260.
21. Kemeny N, Seiter K, Conti JA, Cohen A, Bertino JR, Sigurdson ER, et al: Hepatic arterial floxuridine and leucovorin for unresectable liver metastases from colorectal carcinoma. Cancer 1994; 73:1134-1142.
22. Kemeny N, Fata F: Arterial, portal, or systemic chemotherapy for patients with hepatic metastases of colorectal carcinoma. J Hepatobiliary Pancreat Surg 1999; 6:39-49.
23. Kemeny NE, Ron IG: Hepatic arterial chemotherapy in metastatic colorectal patients. Semin Oncol 1999; 26:524-535.
24. Lorenz M, Staib-Sebler E, Gog C, Petrowsky H, Kohne CH, Eneke A: A pilot study on intensive weekly 24-hour intra-arterial infusion with 5-fluorouracil and folinic acid for colorectal liver metastases. Oncology 1998; 55:53-58.
25. Ambiru S, Miyazaki M, Ito H, Nakagawa K, Shimizu H, Nakajima N: Adjuvant regional chemotherapy after hepatic resection for colorectal metastases. Br J Surg 1999; 86:1025-1031.
26. Rougier P, Sahmoud T, Nitti D, Curran D, Doci R, Waele BD, et al: Adjuvant portal-vein infusion of fluorouracil and heparin in colorectal cancer. Lancet 1998; 351:1677-1681.
27. Breedis C, Young C: The blood supply of neoplasms in the liver. Am J Path 1954; 30:148-158.
28. Taniguchi H, Daidoh T, Shioaki Y, Takahashi T: Blood supply and drug delivary to primary and secondary human liver cancers studied with in vivo bromodeoxyuridine labeling. Cancer 1993; 71:50-55.
29. Kemeny N, Daly J, Reichman B, Geller N, Botet J, Oderman P: Intrahepatic or systemic infusion of fluorodeoxyuridine in patients with liver metastases from colorectal carcinoma. Ann Int Med 1987; 107:459-465.
30. Leen E, Goldberg JA, Robertson J, Angerson WJ, Sutherland GR, Cooke TG, et al: Early detection of occult colorectal hepatic metastases using duplex colour Doppler sonography. Br J Surg 1993; 80:1249-1251.
31. Leggett DA, Kelley BB, Bunce IH, Miles KA: Colorectal cancer: Diagnostic potential of CT measurements of hepatic perfusion and implications for contrast enhancement protocols. Radiology 1997; 205:716-720.
32. Leveson SH, Wiggins PA, Giles GR, Parkin A, Robinson PJ: Deranged liver blood flow patterns in the detection of liver metastases. Br J Surg 1985; 72:128-130.
33. Chen BC, Huang SC, Germano G, Kuhle W, Hawkins RA, Buxton D, et al: Noninvasive quantification of hepatic arterial blood flow with nitrogen-13-ammonia and dynamic positron emission tomography. J Nucl Med 1991; 32:2199-206.
34. Parkin A, Robinson PJ, Baxter P, Leveson SH, Wiggins PA, Giles GR: Liver perfusion scintigraphy: method, normal range and laparotomy correlation in 100 patients. Nucl Med Commun 1983; 4:395.
35. Hanson KM, Johnson PC: Local control of hepatic arterial and portal venous flow in the dog. Am J Physiol 1966; 211:712-720.
36. Lautt WW: Mechanism and role of intrinsic regulation of hepatic arterial blood flow: hepatic arterial buffer response. Am J Physiol 1985; 249:549-556.
37. Iwao T, Toyonaga A, Shigemori H, Oho K, Sakai T, Tayama C, Masumoto H, Sato M, Tanikawa K: Hepatic artery hemodynamic responsiveness to altered portal blood flow in normal and cirrhotic livers. Radiology 1996; 200:793-798.
38. Rocheleau B, Ethier C, Houle R, Huet PM, Bilodeau M: Hepatic artery buffer response following left portal vein ligation: its role in liver tissue homeostasis. Am J Physiol 1999; 277:1000-1007.
39. Lautt WW, Legare DJ, Daniels TR: The comparative effect of administration of substances via the hepatic artery or portal vein on hepatic arterial resistance, liver blood volume and hepatic extraction in cats. Hepatology 1984; 4:927-932.
40. Ridge JA, Bading JR, Gelbard AS, Benua RS, Daly JM: Perfusion of colorectal hepatic metastases. Relative distribution of flow from the hepatic artery and portal vein. Cancer 1987; 59:1547-1553.
41. Carter R, Anderson JH, Cooke TG, Baxter JN, Angerson WJ: Splanchnic blood flow changes in the presence of hepatic tumour: evidence of a humoral mediator. Br J Cancer 1994; 69:1025-1026.
42. Leen E, Goldberg JA, Angerson WJ, McArdle CS: Potential role of Doppler perfusion index in selection of patients with colorectal cancer for adjuvant chemotherapy. Lancet 2000; 355:34-37.